Market Snapshot
S&P Futures
3,819
Dow Futures
30,822
Nasdaq Futures
11,785
Bone Biologics Corporation (BBLG) stock rallied over 1.67% intraday to trade at $1.22 a share on NASDAQ. The stock opened with a gain of 1.67% at $1.24 and touched an intraday high of $1.31, rising 1.67% against the last close of $1.2. The stock went to a low of $1.2 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-06 | $1.24 | $1.31 | $1.2 | $1.22 | 9,603 |
2022-07-05 | $1.2 | $1.26 | $1.2 | $1.2 | 2,000 |
2022-07-01 | $1.2 | $1.29 | $1.2 | $1.28 | 1,900 |
2022-06-30 | $1.36 | $1.4 | $1.18 | $1.4 | 13,500 |
2022-06-29 | $1.56 | $1.57 | $1.41 | $1.44 | 2,700 |
2022-06-28 | $1.51 | $1.58 | $1.44 | $1.58 | 9,100 |
2022-06-27 | $1.54 | $1.7 | $1.54 | $1.61 | 2,100 |
2022-06-24 | $1.452 | $1.65 | $1.45 | $1.626 | 26,700 |
2022-06-23 | $1.42 | $1.65 | $1.34 | $1.54 | 22,900 |
2022-06-22 | $1.29 | $1.5 | $1.2 | $1.445 | 34,500 |
Employees-
Beta-
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Bone Biologics Corporation (NASDAQ: BBLG) stock price is $1.22 as of the last check on Wednesday, July 6. During the trading session, BBLG stock reached the peak price of $1.31 while $1.2 was the lowest point it dropped to.
The NASDAQ listed BBLG is part of Biotechnology industry that operates in the broader Health Care sector. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration.
Mr. Jeffrey Frelick
Pres & CEO
Ms. Deina H. Walsh
Chief Financial Officer
Dr. Shun'ichi Kuroda
Co-Founder & Member of Scientific Advisory Board
BBLG stock traded closed the last session at $1.22, which is $0.02 or 1.67% lower than its previous close of $1.2. BBLG's current trading price is 7.96% lower than its 52-week high of $7.12 where as its distance from 52-week low of 1.13% is -82.87%.
Number of BBLG employees currently stands at -. BBLG operates from 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803, United States.
Official Webiste of $BBLG is: https://www.bonebiologics.com
BBLG could be contacted at BBLG operates from 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803, United States, or at phone #781 552 4452 and can also be accessed through its website.
BBLG stock volume for the day was 9,603 shares while in the previous session number of BBLG shares traded was 9,603 . The average number of BBLG shares traded daily for last 3 months was 25.25 Thousands.
The percentage change in BBLG stock occurred in the recent session was 1.67% while the dollar amount for the price change in BBLG stock was $0.02.
In the recent session, the day high for BBLG stock was $1.31 while the low for BBLG stock touched on the day was $1.2.
The market value of BBLG currently stands at 13.82 Million with its latest stock price at $1.22 and 10.35 Million of its shares outstanding.